MAPT and Alzheimer disease: Furthermore, the mutated forms of APP or Presenilin-1 and-2 that allow these models to produce AD-like pathology are associated with fAD, which is much less common than sAD, and the MAPT and P301S mutations that allow them to produce tau are not associated with AD at all.